Nova Eye Medical (ASX: EYE) — Company Overview, News & Financial Data
Nova Eye Medical is an Australian medical device company focused on glaucoma treatment options and advanced technologies.
Nova Eye Medical
Nova Eye Medical is a medical technology company specializing in the design, development, and commercialization of ophthalmic devices and surgical technologies for the treatment of glaucoma and retinal disease. Headquartered in Australia with commercial operations across North America, Europe, and Asia-Pacific, the company develops interventional glaucoma products designed to restore natural fluid drainage within the eye. Its commercial portfolio includes microcatheters for canaloplasty procedures, glaucoma drainage implants for advanced cases, and proprietary viscoelastic delivery tools used by ophthalmic surgeons in clinical settings worldwide.
Snapshot
Operations
Products and/or services of Nova Eye Medical
- Canaloplasty Microcatheters: Handheld illuminated microcatheters with integrated delivery systems designed for catheterization and viscodilation of Schlemm canal, enabling minimally invasive glaucoma surgery across outpatient surgical centers and hospital operating rooms globally.
- Glaucoma Drainage Implants: Polypropylene glaucoma drainage devices featuring a thin four-millimeter plate designed to sit against the sclera, providing intraocular pressure reduction in severe and refractory open-angle glaucoma cases across international healthcare markets.
- Viscoelastic Delivery Systems: Specialized delivery handpieces and fluid manipulation technologies that transform cohesive viscoelastic into lower-viscosity fluid during canaloplasty to facilitate fluid penetration throughout the eye's conventional outflow pathways during surgery.
- Goniotomy Instruments: Ophthalmic surgical tools engineered for trabecular meshwork disruption, tissue cutting, and fluid aspiration during ab interno surgical glaucoma procedures performed by ophthalmic specialists in hospital operating rooms.
- Retinal Laser Therapies: Nanosecond pulse laser systems designed for non-thermal rejuvenation of the retinal pigment epithelium, targeting early-stage age-related macular degeneration and diabetic macular edema across clinical evaluation sites.
- Surgical Education Programs: Medical education platforms, clinical webinars, and hands-on wet lab training sessions provided to ophthalmic surgeons and glaucoma specialists across primary operating markets in North America, Europe, and Asia-Pacific.
Nova Eye Medical executive team
- Mr. Victor PrevinFounder & Executive Chairman
- Mr. Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D.MD & Executive Director
- Ms. Kimberley MenziesChief Financial Officer
- Mark FlynnInvestor Relations
- Ms. Kate HuntChief Commercial Officer
- Mr. Joe BankovichPresident of Global Sales
- Mr. Joaquin V. WolffPresident of Ellex iTrack
- Mr. Simon Jeremy Newton Gray BEc, C.A.Company Secretary
- Jordan PossinghamFinancial Controller
- Mr. Don WattonVice President of Global Service